Anti-proliferative effect of retinoids and interferon-α-2a on vaginal cell lines derived from squamous intra-epithelial lesions

International Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 338-345

  Hietanen, Sakari ^a,b   Auvinen, Eeva ^c   Syrjänen, Kari ^d   Syrjänen, Stina ^a,e  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e TURKU UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CALCIUM; RETINOID;

ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION; CONCENTRATION (PARAMETERS); DRUG EFFECT; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ACITRETIN; CARCINOMA IN SITU; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLASTS; HUMANS; INTERFERON ALFA-2A; ISOTRETINOIN; KERATINOCYTES; RETINOIDS; TRETINOIN; TUMOR CELLS, CULTURED; VAGINA; VAGINAL NEOPLASMS;

EID: 0032578699     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981029)78:3<338::AID-IJC14>3.0.CO;2-2     Document Type: Article

References (30)

1. AGARWAL, C., HEMBREE, J.R., RORKE, E.A. and ECKERT, R.L., Interferon and retinoic acid suppress the growth of human-papillomavirus-type-16-immortulized cervical epithelial cells, but only interferon suppresses the level of the human-papillomavirus-transforming oncogenes. Cancer Res., 54, 2108-2112 (1994).
2. AGARWAL, C., RORKE, E.A., IRWTN, J.C. and ECKERT, R.L., Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res., 51, 3982-3989 (1991).
3. AKHURST, R.J., FEE, F. and BALMAIN, A., Localized production of TGF-beta mRNA in tumour-promoter-stimulated mouse epidermis. Nature (Lond.), 331, 363-365 (1988).
4. BARTSCH, D., BOYE, B., BAUST, C., ZUR HAUSEN, H. and SCHWARZ, E., Retinoic-acid-mediated repression of human-papillomavirus-18 transcription and different ligand regulation of the retinoic-acid-receptor-beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J., 11, 2283-2291 (1992).
5. BATOVA, A., DANIELPOUR, D., PIRISI, L. and CREEK, K.E., Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human-papillomavirus-type-16-immortalized human keratinocytes. Cell Growth Differ., 3, 763-772 (1992).
6. BOLLAG, W. and PECK, R., Modulation of growth and differentiation by combined retinoids and cytokines in cancer. In: W. Hong and R. Lotan (eds.), Retinoids in oncology, pp. 89-108, Marcel Dekker, New York (1993).
7. CORY, A.H., OWEN, T.C., BARLTROP, J.A. and CORY, J.G., Use of an aqueous soluble tetrazolium/formazan assay for cell-growth assays in culture. Cancer Comm., 3, 207-212 (1991).
8. DANIELPOUR, D., Induction of transforming-growth-factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. J. cell. Phvsiol., 166, 231-239 (1996).
9. GLICK, A.B., DANIELPOUR, D., MORGAN, D., SPORN, M.B. and YUSPA, S.H., Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytes. Mol. Endocrinol., 4, 46-52 (1990).
10. GLICK, A.B., FLANDERS, K.C., DANIELPOUR, D., YUSPA, S.H. and SPORN, M.B., Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. Cell Regul. 1, 87-97 (1989).
11. GRAHAM, V., SURWIT, E.S., WEINER, S. and MEYSKENS, F.L., JR., Phase-II trial of beta-all-rratts-retinoic acid for cervical intra-epithelial neopiasia delivered via a collagen sponge and cervical cap. West. J. Med., 145, 192-195 (1986).
12. GUDAS, L.J., SPORN, M.B. and ROBERTS, A.B., Cellular biology and biochemistry of the retinoids. In: M.B. Sporn, A.B. Roberts and D.S. Goodman (eds.), The retinoids: biology, chemistry and medicine, 2nd Ed., pp. 443-520, Raven Press, New York (1994).
13. HTETANEN, S., AUVINEN, E., GRÉNMAN, S., LAKKALA, T., SAJANTILA, A., KLEMI, P. and MÄENPÄÄ, J., Isolation of two keratinocyte cell lines derived from HPV-positive dysplastic vaginal lesions. Int. J. Cancer, 52, 391-398 (1992).
14. HIETANEN, S., SYRJÄNEN, S. and SYRJÄNEN, K., Characterization of keratin and cell-cycle protein expression in cell Lines from squamous intraepithelial lesion progressing towards a malignant phenotype. Brit. J. Cancer, 77, 766-775 (1998).
15. HOSSAIN, M.Z. and BERTRAM, J.S., Retinoids suppress proliferation, induce cell spreading, and up-regulate connexin-43 expression only. in post- confluent 10T0/2 cells: implications for the role of gap junctional communication. Cell Growth Differ, 5, 1253-1261 (1994).
16. KHAN, M.A., TOLLESON, W.H., GANGEMI, J.D. and PIRISI, L., Inhibition of growth, transformation and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons. J. Virol., 67, 3396-3403 (1993).
17. KOPAN, R., TRASKA, G. and FUCHS, E., Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. J. Cell Biol., 105, 427-440 (1987).
18. LIPPMAN, S.M., KAVANAGH, J.J., PAREDES ESPINOZA, M., DELGADILLO MADRUENO, F., PAREDES CASILLAS, P., HONG, W.K., MASSIMINI, G., HOLDENER, E.E. and KRAKOFF, I.H., 13-ics-retinoic acid plus interferon-alpha 2a in locally advanced squamous-cell carcinoma of the cervix. J. nat. Cancer Inst., 85, 499-500 (1993).
19. LOT AN, R., Retinoids and squamous-cell differentiation. In: W. Hong and R. Lotan (eds.), Retinoids in oncology, pp. 3-72, Marcel Dekker, New York (1993).
20. MCMICHAEL, H., Inhibition of growth of Shope-rabbit papilloma by hypervitaminosis A. Cancer Res., 25, 947-955 (1965).
21. MERRICK, D.T., GOWN, A.M., HALBERT, C.L., BLANTON, R.A. and MCDOUGALL, J.K., Human-papilloma-virus-immortalized keratinocytes are resistant to the effects of retinoic acid on terminal differentiation. Cell Growth Differ., 4, 831-840 (1993).
22. MEYSKENS, F.L., SURWIT, E., MOON, T.E., CHILDERS, J.M., DAVIS, J.R., DORR, R.T., JOHNSON, C.S. and ALBERTS, D.S., Enhancement of regression of cervical intra-epithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J. nat. Cancer Inst., 86, 539-543 (1994).
23. PALAN, P.R., MIKHAIL, M.S., BASU, J. and ROMNEY, S.L., Plasma levels of anti-oxidant beta-carotene and alpha-tocopherol in uterine cervix dysplasias and cancer. Nutr: Cancer, 15, 13-20 (1991).
24. PIRISI, L., BATOVA, A., JENKINS, G.R., HODAM, J.R. and CREEK, K.E., Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16. Cancer Res., 52, 187-193 (1992).
25. ROBERTS, A.B., THOMPSON, N.L., HEINE, U., FLANDERS, C. and SPORN, M.B., Transforming growth factor-beta: possible roles in carcinogenesis. Brit. J. Cancer, 57, 594-600 (1988).
26. ROCKLEY, P.F. and TYRING, S.K., Interferon-alpha, -beta and -gamma therapy of anogenital human-papillomavirus infections. Pharmacol. Ther., 65, 265-287 (1995).
27. SARMA, D., YANG, X., JIN, G., SHINDOH, M., PATER, M.M. and PATER, A., Resistance to retinoic acid and altered cytokeratin expression of humanpapillomavirus-type-16-immortalized endocervical cells after tumorigenesis. Int. J. Cancer, 65, 345-350 (1996).
28. SAUNDERS, N.A. and JETTEN, A.M., Control of growth-regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1.7. biol. Chem., 269, 2016-2022 (1994).
29. TONG, P.S., MAYES, D.M. and WHEELER, L.A., Differential effects of retinoids on DNA synthesis in calcium-regulated murine epidermal keratinocyte cultures. J. Invest. Dermatol., 90, 861-868 (1988).
30. VERMA, A.K., SHAPAS, B.G., RICE, H.M. and BOUTWELL. R.K., Correlation of the inhibition by retinoids of tumor-promoter-induced mouse-epidermal-ornithine-decarboxylase activity and of skin-tumor promotion. Cancer Res., 39, 419-425 (1979).